PV
Palvella Therapeutics, Inc. (PVLA)
NASDAQ·Healthcare·Biotechnology
$153.91
+9.33%
Mkt Cap $2.05B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (33 analysts)
$232.00
Range $210.00 – $270.00
Implied Upside
+50.7%
Consensus $232.00 vs current $153.91